FGFR3 and urothelial carcinoma: Furthermore, we show that in two of the most common FGFR3 extracellular cysteine mutants in urothelial carcinoma (S249C and R248C), the constitutive receptor dimerization mediated by the cysteine residue is necessary for driving dasatinib resistance.